Treating Yourself as an Object: Self-Objectification and the Ethical Dimensions of Antidepressant Use
- Ginger A. Hoffman
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
In this paper, I offer one moral reason to eschew antidepressant medication in favor of cognitive therapy, all other things being equal: taking antidepressants can be a form of self-objectification. This means that, by taking antidepressants, one treats oneself, in some sense and some cases, like a mere object. I contend that, morally, this amounts to a specific form of devaluing oneself. I argue this as follows. First, I offer a detailed definition of “objectification” and argue for the possibility of self-objectification on this definition. I then explain why this form of self-objectification is morally problematic. (Morally problematic does not mean morally impermissible. It means, instead, that there is a moral reason opposing the activity in question). After, I describe how taking antidepressants can count as self-objectifying. Finally, I defend my thesis against a key objection offered by Levy. Thus, assuming that antidepressants and cognitive therapy are equally efficacious, and that all other things are equal, the self-objectifying character of antidepressants is a compelling reason to regard cognitive therapy as a first-choice treatment for depression.
- Kramer, Peter. 1997. Listening to Prozac. Middlesex, UK: Penguin.
- Beck, Aaron T., A. John Rush, Brian F. Shaw, and Gary Emery. 1979. Cognitive therapy of depression. New York: The Guilford Press.
- David, Daniel, and Aurora Szentagotai. 2008. Rational emotive behavior therapy, cognitive therapy, and medication in the treatment of major depressive disorder: A randomized clinical trial, posttreatment outcomes, and six-month follow-up. Journal of Clinical Psychology 64: 728–746. CrossRef
- Hollon, Steven D., Robert J. DeRubeis, Mark D. Evans, Marlin J. Wiemer, Michael J. Garvey, William M. Grove, and Vicente B. Tuason. 1992. Cognitive therapy and pharmacotherapy for depression: Singly and in combination. Archives of General Psychiatry 49: 774–781. CrossRef
- Elkin, Irene, Tracie Shea, John T. Watkins, Stanley D. Imber, Stuart M. Sotsky, Joseph F. Collins, David R. Glass, Paul A. Pilkonis, William R. Leber, John P. Docherty, Susan J. Fiester, and Moris B. Parloff. 1989. National Institute of Mental Health treatment of depression collaborative research program. Archives of General Psychiatry 46: 971–982. CrossRef
- DeRubeis, Robert J., Steven J. Hollon, Jay D. Amsterdam, Richard C. Shelton, Paula R. Young, Ronald M. Salomon, John P. O’Reardon, Margaret L. Lovett, Madeline M. Gladis, Laurel L. Brown, and Robert Gallop. 2005. Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of General Psychiatry 65: 409–416. CrossRef
- Marcus, Steven C., and Olfson, Mark. 2010. National trends in the treatment for Depression from 1998 to 2007. Archives of General Psychiatry 67(12): 1265–1273.
- Ross, William D. 1930. The right and the good. Oxford: Oxford University Press.
- Elliott, Carl. 1998. The tyranny of happiness: Ethics and cosmetic psychopharmacology. In Enhancing human traits: Ethical and social implications, ed. Erik Parens, 177–188. Washington, D.C.: Georgetown University Press.
- Biegler, Paul. 2010. Autonomy and ethical treatment in depression. Bioethics 24: 179–189. CrossRef
- Levy, Neil. 2007. Neuroethics. Cambridge: Cambridge University Press. CrossRef
- Manninen, Bertha A. 2006. Medicating the mind: A Kantian analysis of overprescribing psychoactive drugs. Journal of Medical Ethics 32: 100–105. CrossRef
- Freedman, Carol. 1998. Aspirin for the mind? Some ethical worries about psychopharmacology. In Enhancing human traits: Ethical and social implications, ed. Erik Parens, 135–150. Washington, D.C.: Georgetown University Press.
- Nussbaum, Martha. 1995. Objectification. Philosophy and Public Affairs 24: 249–291. CrossRef
- Langton, Rae. 2009. Sexual solipsism. Oxford: Oxford University Press. CrossRef
- Kant, Immanuel. 1785. Groundwork of the metaphysics of morals. In Practical philosophy, ed. and trans. Mary J. Gregor, 1996. Cambridge, Cambridge University Press.
- American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, fourth edition, text revision. Arlington, VA: American Psychiatric Association.
- Biegler, Paul. 2011. The ethical treatment of depression: autonomy through psychotherapy. Cambridge: MIT Press.
- Elliott, Carl. 2003. Better than well: American medicine meets the American dream. New York: Norton Press.
- DeGrazia, David. 2000. Prozac, enhancement, and self-creation. The Hastings Center Report 30(2): 34–40. CrossRef
- Haslanger, Sally. 2002. On being objective and being objectified. In A mind of one’s own, ed. Louise Antony and Charlotte Witt, 98–101. Boulder, CO: Westview Press.
- Papadaki, Lina. 2010. What is objectification? Journal of Moral Philosophy 7: 16–36. CrossRef
- Kant, Immanuel. 1797. Metaphysics of morals. In Practical philosophy, ed. and trans. Mary J. Gregor, 1996. Cambridge, Cambridge University Press.
- Larson, Mary Jo, Kay Miller, and Kathleen J. Fleming. 2006. Antidepressant medication use in private health insurance plans, 2002. Psychiatric Services 57(2): 175. CrossRef
- Kraemer, Felicitas. 2011. Authenticity anyone? The enhancement of emotions via neuro-psychopharmacology. Neuroethics 4: 51–64. CrossRef
- Treating Yourself as an Object: Self-Objectification and the Ethical Dimensions of Antidepressant Use
Volume 6, Issue 1 , pp 165-178
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Cognitive therapy
- Author Affiliations
- 1. Department of Philosophy, Saint Joseph’s University, 5600 City Avenue, Philadelphia, PA, 19131, USA